Table 1 Baseline characteristics of early RA patients from the tREACH

Patients, N

294

Male, N (%)

87.0 (29.6%)

Age (years)

53.4 ± 14.2

DAS28 score

4.7 ± 1.2

DAS28 score 3 months*

3.0 ± 1.2

Erythrocyte folate (nmol/L)*

936.0 ± 356.2

BMI (kg/m²)*

26.3 ± 5.1

 Current, N (%)

91.0 (31.0%)

 Never + former, N (%)

180.0 (61.2%)

 Positive, N (%)

193 (65.6%)

 MTX, N (%)

54.0 (18.4%)

 MTX + prednisone p.o., N (%)

81.0 (27.6%)

 MTX + SSZ + HCQ + prednisone p.o., N (%)

83.0 (28.2%)

 MTX + SSZ + HCQ + corticosteroids i.m., N (%)

76.0 (25.9%)